3-Substituted Quinolines as RORγt Inverse Agonists
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (12) , 1463-1470
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The psoriasis drugs marketNature Reviews Drug Discovery, 2015
- Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of ActionACS Medicinal Chemistry Letters, 2014
- ROR nuclear receptors: structures, related diseases, and drug discoveryActa Pharmacologica Sinica, 2014
- Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiationProceedings of the National Academy of Sciences, 2014
- Targeting the Th17 pathway in psoriasisJournal of Leukocyte Biology, 2012
- IL-23/IL-17 axis in IBDInflammatory Bowel Diseases, 2010
- Retinoid-Related Orphan Receptors (RORs): Critical Roles in Development, Immunity, Circadian Rhythm, and Cellular MetabolismNuclear Receptor Signaling, 2009
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- Thermodynamic Stability of Carbonic Anhydrase: Measurements of Binding Affinity and Stoichiometry Using ThermoFluorBiochemistry, 2005
- High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug DiscoverySLAS Discovery, 2001